Sort   by:  
 Page size 
TranscriptomicsBreast cancer cell lines treated with eribulin and paclitaxel
Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics, leading to inhibition of microtubule growth in the absence of effects on microtubule shortening at microtubule plus ...
ORGANISM(S): Homo sapiens 
2014-10-02 | E-GEOD-50811 | biostudies-arrayexpress
TranscriptomicsEndometrial cancer cell lines treated with eribulin and paclitaxel
Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics, leading to inhibition of microtubule growth in the absence of effects on microtubule shortening at microtubule plus ...
ORGANISM(S): Homo sapiens 
2014-10-02 | E-GEOD-50830 | biostudies-arrayexpress
TranscriptomicsOvarian cancer cell lines treated with eribulin and paclitaxel
Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics, leading to inhibition of microtubule growth in the absence of effects on microtubule shortening at microtubule plus ...
ORGANISM(S): Homo sapiens 
2014-10-02 | E-GEOD-50831 | biostudies-arrayexpress
ProteomicsThe Yin and Yang of GDF15: a secreted biomarker of eribulin response in breast cancer cells, yet required for survival of drug tolerant persister (DTP) cells
Drug tolerant persister (DTP) cells enter into a reversible slow-cycling state after cancer drug treatment. These cells are the living proof of response to a drug, and an interesting experimental subject for biomarker discovery. Here, we performed proteomic characterization of the breast cancer (BC)...
ORGANISM(S): Homo sapiens (Human) 
2023-01-09 | PXD034037 | Pride
Eribulin Drug tolerance Growth differentiation factor (gdf15) Secretome. Drug tolerant persister (dtp) Breast cancer (bc) 
UnknownPatient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide.
Not available
S-EPMC4822111 | biostudies-literature
TranscriptomicsGene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Homo sapiens 
2014-10-02 | E-GEOD-50832 | biostudies-arrayexpress
GenomicsA phase II study of triple combination of atezolizumab+ cobimetinib + eribulin (ACE) or atezolizumab + eribulin (AE) in patients with recurrent/metastatic inflammatory breast cancer
A phase II study of triple combination of atezolizumab+ cobimetinib + eribulin (ACE) or atezolizumab + eribulin (AE) in patients with recurrent/metastatic inflammatory breast cancer
PRJNA1508195 | ENA
TranscriptomicsBreast cancer cell lines treated with eribulin and paclitaxel
Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics, leading to inhibition of microtubule growth in the absence of effects on microtubule shortening at microtubule plus ...
ORGANISM(S): Homo sapiens 
2014-10-02 | GSE50811 | GEO
TranscriptomicsEndometrial cancer cell lines treated with eribulin and paclitaxel
Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics, leading to inhibition of microtubule growth in the absence of effects on microtubule shortening at microtubule plus ...
ORGANISM(S): Homo sapiens 
2014-10-02 | GSE50830 | GEO
TranscriptomicsOvarian cancer cell lines treated with eribulin and paclitaxel
Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics, leading to inhibition of microtubule growth in the absence of effects on microtubule shortening at microtubule plus ...
ORGANISM(S): Homo sapiens 
2014-10-02 | GSE50831 | GEO
Sort   by:  
 Page size